BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32404579)

  • 21. Enhancing Boron Uptake in Brain Glioma by a Boron-Polymer/Microbubble Complex with Focused Ultrasound.
    Fan CH; Wang TW; Hsieh YK; Wang CF; Gao Z; Kim A; Nagasaki Y; Yeh CK
    ACS Appl Mater Interfaces; 2019 Mar; 11(12):11144-11156. PubMed ID: 30883079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards new boron carriers for boron neutron capture therapy: metallacarboranes bearing cobalt, iron and chromium and their cholesterol conjugates.
    Białek-Pietras M; Olejniczak AB; Tachikawa S; Nakamura H; Leśnikowski ZJ
    Bioorg Med Chem; 2013 Mar; 21(5):1136-42. PubMed ID: 23357039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy.
    Worm DJ; Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Med Chem; 2020 Mar; 63(5):2358-2371. PubMed ID: 31589041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
    J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On-Demand Biodegradable Boron Nitride Nanoparticles for Treating Triple Negative Breast Cancer with Boron Neutron Capture Therapy.
    Li L; Li J; Shi Y; Du P; Zhang Z; Liu T; Zhang R; Liu Z
    ACS Nano; 2019 Dec; 13(12):13843-13852. PubMed ID: 31697475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
    Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.
    Li J; Shi Y; Zhang Z; Liu H; Lang L; Liu T; Chen X; Liu Z
    Bioconjug Chem; 2019 Nov; 30(11):2870-2878. PubMed ID: 31593447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carborane Derivative Conjugated with Gold Nanoclusters for Targeted Cancer Cell Imaging.
    Wang J; Chen L; Ye J; Li Z; Jiang H; Yan H; Stogniy MY; Sivaev IB; Bregadze VI; Wang X
    Biomacromolecules; 2017 May; 18(5):1466-1472. PubMed ID: 28351146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological activity of N(4)-boronated derivatives of 2'-deoxycytidine, potential agents for boron-neutron capture therapy.
    Nizioł J; Uram Ł; Szuster M; Sekuła J; Ruman T
    Bioorg Med Chem; 2015 Oct; 23(19):6297-304. PubMed ID: 26344594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects.
    Gao Z; Horiguchi Y; Nakai K; Matsumura A; Suzuki M; Ono K; Nagasaki Y
    Biomaterials; 2016 Oct; 104():201-12. PubMed ID: 27467416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas.
    Dai C; Cai F; Hwang KC; Zhou Y; Zhang Z; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wei J; Jiao Y; Wei Z; Ma W; Wang R
    Sci China Life Sci; 2013 Feb; 56(2):163-73. PubMed ID: 23334699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy].
    Nakamura H
    Yakugaku Zasshi; 2013; 133(12):1297-306. PubMed ID: 24292174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
    Hiramatsu R; Kawabata S; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake S; Kuroiwa T; Hao E; Vicente MG
    J Pharm Sci; 2015 Mar; 104(3):962-70. PubMed ID: 25546823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment.
    Alberti D; Protti N; Toppino A; Deagostino A; Lanzardo S; Bortolussi S; Altieri S; Voena C; Chiarle R; Geninatti Crich S; Aime S
    Nanomedicine; 2015 Apr; 11(3):741-50. PubMed ID: 25596074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of cathepsin B-responsive fluorescent probe and photosensitizer using a ferrocenyl boron dipyrromethene dark quencher.
    Wang Q; Yu L; Wong RCH; Lo PC
    Eur J Med Chem; 2019 Oct; 179():828-836. PubMed ID: 31295715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
    Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
    Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
    [No Abstract]   [Full Text] [Related]  

  • 39. Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter.
    Miyabe J; Ohgaki R; Saito K; Wei L; Quan L; Jin C; Liu X; Okuda S; Nagamori S; Ohki H; Yoshino K; Inohara H; Kanai Y
    J Pharmacol Sci; 2019 Mar; 139(3):215-222. PubMed ID: 30833090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
    Miyata S; Kawabata S; Hiramatsu R; Doi A; Ikeda N; Yamashita T; Kuroiwa T; Kasaoka S; Maruyama K; Miyatake S
    Neurosurgery; 2011 May; 68(5):1380-7; discussion 1387. PubMed ID: 21273928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.